Autoantibodies in systemic autoimmune diseases: Specificity and pathogenicity

Journal of Clinical Investigation

Volumn 125, Issue 6, 2015, Pages 2194-2202

  Suurmond, Jolien ^a   Diamond, Betty ^a  

^a FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; TOLL LIKE RECEPTOR; AUTOANTIGEN;

ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; ANTIGEN ANTIBODY COMPLEX; ANTIGEN RECOGNITION; ARTICLE; AUTOIMMUNE DISEASE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; CHRONIC INFLAMMATION; HUMAN; IMMUNOLOGICAL TOLERANCE; LYMPHOCYTOPOIESIS; NONHUMAN; PATHOGENICITY; PRIORITY JOURNAL; PROTEIN TARGETING; SYSTEMIC DISEASE; T LYMPHOCYTE; ANIMAL; BONE MARROW CELL; IMMUNOLOGY; PATHOLOGY;

ANIMALS; ANTIBODY FORMATION; AUTOANTIBODIES; AUTOANTIGENS; AUTOIMMUNE DISEASES; B-LYMPHOCYTES; HUMANS; IMMUNE TOLERANCE; MYELOID CELLS; T-LYMPHOCYTES;

EID: 84930407494     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI78084     Document Type: Article

References (111)

1. Robbins WC, Holman HR, Deicher H, Kunkel HG. Complement fixation with cell nuclei and DNA in lupus erythematosus. Proc Soc Exp Biol Med. 1957;96(3): 575-579.
2. Miescher P, Fauconnet M. [Absorption of L. E. factor by isolated cell nuclei]. Experientia. 1954;10(6): 252-253.
3. Mackay IR. Travels and travails of autoimmunity: A historical journey from discovery to rediscovery. Autoimmun Rev. 2010;9(5): A251-A258.
4. Loder F, et al. B cell development in the spleen takes place in discrete steps and is determined by the quality of B cell receptor-derived signals. J Exp Med. 1999;190(1): 75-89.
5. Rice JS, Newman J, Wang C, Michael DJ, Diamond B. Receptor editing in peripheral B cell tolerance. Proc Natl Acad Sci U S A. 2005;102(5): 1608-1613.
6. Pulendran B, Kannourakis G, Nouri S, Smith KG, Nossal GJ. Soluble antigen can cause enhanced apoptosis of germinal-centre B cells. Nature. 1995;375(6529): 331-334.
7. Wardemann H, Yurasov S, Schaefer A, Young JW, Meffre E, Nussenzweig MC. Predominant autoantibody production by early human B cell precursors. Science. 2003;301(5638): 1374-1377.
8. Pao LI, et al. B cell-specific deletion of proteintyrosine phosphatase Shp1 promotes B-1a cell development and causes systemic autoimmunity. Immunity. 2007;27(1): 35-48.
9. Thien M, et al. Excess BAFF rescues self-reactive B cells from peripheral deletion and allows them to enter forbidden follicular and marginal zone niches. Immunity. 2004;20(6): 785-798.
10. Batten M, et al. BAFF mediates survival of peripheral immature B lymphocytes. J Exp Med. 2000;192(10): 1453-1466.
11. Samuels J, Ng YS, Coupillaud C, Paget D, Meffre E. Impaired early B cell tolerance in patients with rheumatoid arthritis. J Exp Med. 2005;201(10): 1659-1667.
12. Yurasov S, et al. Defective B cell tolerance checkpoints in systemic lupus erythematosus. J Exp Med. 2005;201(5): 703-711.
13. Giles IP, Haley JD, Nagl S, Isenberg DA, Latchman DS, Rahman A. A systematic analysis of sequences of human antiphospholipid and anti-β2-glycoprotein I antibodies: The importance of somatic mutations and certain sequence motifs. Semin Arthritis Rheum. 2003;32(4): 246-265.
14. Schroder AE, Greiner A, Seyfert C, Berek C. Differentiation of B cells in the nonlymphoid tissue of the synovial membrane of patients with rheumatoid arthritis. Proc Natl Acad Sci U S A. 1996;93(1): 221-225.
15. Carayannopoulos MO, Potter KN, Li Y, Natvig JB, Capra JD. Evidence that human immunoglobulin M rheumatoid factors can Be derived from the natural autoantibody pool and undergo an antigen driven immune response in which somatically mutated rheumatoid factors have lower affinities for immunoglobulin G Fc than their germline counterparts. Scand J Immunol. 2000;51(4): 327-336.
16. Diamond B, Scharff MD. Somatic mutation of the T15 heavy chain gives rise to an antibody with autoantibody specificity. Proc Natl Acad Sci U S A. 1984;81(18): 5841-5844.
17. Mietzner B, et al. Autoreactive IgG memory antibodies in patients with systemic lupus erythematosus arise from nonreactive and polyreactive precursors. Proc Natl Acad Sci U S A. 2008;105(28): 9727-9732.
18. Amara K, et al. Monoclonal IgG antibodies generated from joint-derived B cells of RA patients have a strong bias toward citrullinated autoantigen recognition. J Exp Med. 2013;210(3): 445-455.
19. Wellmann U, Letz M, Herrmann M, Angermuller S, Kalden JR, Winkler TH. The evolution of human anti-double-stranded DNA autoantibodies. Proc Natl Acad Sci U S A. 2005;102(26): 9258-9263.
20. Morris DL, et al. MHC associations with clinical and autoantibody manifestations in European SLE. Genes Immun. 2014;15(4): 210-217.
21. Irigoyen P, et al. Regulation of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis: Contrasting effects of HLA-DR3 and the shared epitope alleles. Arthritis Rheum. 2005;52(12): 3813-3818.
22. Scally SW, et al. A molecular basis for the association of the HLA-DRB1 locus, citrullination, and rheumatoid arthritis. J Exp Med. 2013;210(12): 2569-2582.
23. Mohan C, Adams S, Stanik V, Datta SK. Nucleosome: A major immunogen for pathogenic autoantibody- inducing T cells of lupus. J Exp Med. 1993;177(5): 1367-1381.
24. Rekvig OP, et al. Experimental expression in mice and spontaneous expression in human SLE of polyomavirus T-Antigen. A molecular basis for induction of antibodies to DNA and eukaryotic transcription factors. J Clin Invest. 1997;99(8): 2045-2054.
25. Kaliyaperumal A, Mohan C, Wu W, Datta SK. Nucleosomal peptide epitopes for nephritisinducing T helper cells of murine lupus. J Exp Med. 1996;183(6): 2459-2469.
26. Desai-Mehta A, Mao C, Rajagopalan S, Robinson T, Datta SK. Structure and specificity of T cell receptors expressed by potentially pathogenic anti-DNA autoantibody-inducing T cells in human lupus. J Clin Invest. 1995;95(2): 531-541.
27. Ray SK, Putterman C, Diamond B. Pathogenic autoantibodies are routinely generated during the response to foreign antigen: A paradigm for autoimmune disease. Proc Natl Acad Sci U S A. 1996;93(5): 2019-2024.
28. Kain R, et al. Molecular mimicry in pauciimmune focal necrotizing glomerulonephritis. Nat Med. 2008;14(10): 1088-1096.
29. McClain MT, Heinlen LD, Dennis GJ, Roebuck J, Harley JB, James JA. Early events in lupus humoral autoimmunity suggest initiation through molecular mimicry. Nat Med. 2005;11(1): 85-89.
30. Kinloch AJ, et al. Immunization with Porphyromonas gingivalis enolase induces autoimmunity to mammalian alpha-enolase and arthritis in DR4-IE-transgenic mice. Arthritis Rheum. 2011;63(12): 3818-3823.
31. Galvin JE, Hemric ME, Ward K, Cunningham MW. Cytotoxic mAb from rheumatic carditis recognizes heart valves and laminin. J Clin Invest. 2000;106(2): 217-224.
32. Humby F, et al. Ectopic lymphoid structures support ongoing production of class-switched autoantibodies in rheumatoid synovium. PLoS Med. 2009;6(1): E1.
33. Salomonsson S, et al. Cellular basis of ectopic germinal center formation and autoantibody production in the target organ of patients with Sjogren's syndrome. Arthritis Rheum. 2003;48(11): 3187-3201.
34. Willemze A, et al. The ACPA recognition profile and subgrouping of ACPA-positive RA patients. Ann Rheum Dis. 2012;71(2): 268-274.
35. Pratesi F, et al. Antibodies from patients with rheumatoid arthritis target citrullinated histone 4 contained in neutrophils extracellular traps. Ann Rheum Dis. 2014;73(7): 1414-1422.
36. Furnrohr BG, Groer GJ, Sehnert B, Herrmann M, Voll RE. Interaction of histones with phospholipids - implications for the exposure of histones on apoptotic cells. Autoimmunity. 2007;40(4): 322-326.
37. Radic M, Marion T, Monestier M. Nucleosomes are exposed at the cell surface in apoptosis. J Immunol. 2004;172(11): 6692-6700.
38. Hong Y, et al. Anti-neutrophil cytoplasmic antibodies stimulate release of neutrophil microparticles. J Am Soc Nephrol. 2012;23(1): 49-62.
39. Kantari C, et al. Proteinase 3, the Wegener autoantigen, is externalized during neutrophil apoptosis: Evidence for a functional association with phospholipid scramblase 1 and interference with macrophage phagocytosis. Blood. 2007;110(12): 4086-4095.
40. Dwivedi N, Radic M. Citrullination of autoantigens implicates NETosis in the induction of autoimmunity. Ann Rheum Dis. 2014;73(3): 483-491.
41. Dieker JW, et al. Apoptosis-induced acetylation of histones is pathogenic in systemic lupus erythematosus. Arthritis Rheum. 2007;56(6): 1921-1933.
42. Huynh ML, Fadok VA, Henson PM. Phosphatidylserine- dependent ingestion of apoptotic cells promotes TGF-β1 secretion and the resolution of inflammation. J Clin Invest. 2002;109(1): 41-50.
43. Truedsson L, Bengtsson AA, Sturfelt G. Complement deficiencies and systemic lupus erythematosus. Autoimmunity. 2007;40(8): 560-566.
44. Budhai L, Oh K, Davidson A. An in vitro assay for detection of glomerular binding IgG autoantibodies in patients with systemic lupus erythematosus. J Clin Invest. 1996;98(7): 1585-1593.
45. Putterman C, Limpanasithikul W, Edelman M, Diamond B. The double edged sword of the immune response: Mutational analysis of a murine anti-pneumococcal, anti-DNA antibody. J Clin Invest. 1996;97(10): 2251-2259.
46. Franchin G, Son M, Kim SJ, Ben-Zvi I, Zhang J, Diamond B. Anti-DNA antibodies cross-react with C1q. J Autoimmun. 2013;44: 34-39.
47. Krishnan MR, Wang C, Marion TN. Anti-DNA autoantibodies initiate experimental lupus nephritis by binding directly to the glomerular basement membrane in mice. Kidney Int. 2012;82(2): 184-192.
48. Kalaaji M, et al. Glomerular apoptotic nucleosomes are central target structures for nephritogenic antibodies in human SLE nephritis. Kidney Int. 2007;71(7): 664-672.
49. Mjelle JE, Rekvig OP, Van Der Vlag J, Fenton KA. Nephritogenic antibodies bind in glomeruli through interaction with exposed chromatin fragments and not with renal cross-reactive antigens. Autoimmunity. 2011;44(5): 373-383.
50. Ioan-Facsinay A, et al. Anti-cyclic citrullinated peptide antibodies are a collection of anti-citrullinated protein antibodies and contain overlapping and non-overlapping reactivities. Ann Rheum Dis. 2011;70(1): 188-193.
51. Sokolove J, Zhao X, Chandra PE, Robinson WH. Immune complexes containing citrullinated fibrinogen costimulate macrophages via Toll-like receptor 4 and Fc? receptor. Arthritis Rheum. 2011;63(1): 53-62.
52. Zhang P, Cox CJ, Alvarez KM, Cunningham MW. Cutting edge: Cardiac myosin activates innate immune responses through TLRs. J Immunol. 2009;183(1): 27-31.
53. Horkko S, Miller E, Branch DW, Palinski W, Witztum JL. The epitopes for some antiphospholipid antibodies are adducts of oxidized phospholipid and β2 glycoprotein 1 (and other proteins). Proc Natl Acad Sci U S A. 1997;94(19): 10356-10361.
54. Imai Y, et al. Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury. Cell. 2008;133(2): 235-249.
55. Zhou R, Yazdi AS, Menu P, Tschopp J. A role for mitochondria in NLRP3 inflammasome activation. Nature. 2011;469(7329): 221-225.
56. Iyer SS, et al. Mitochondrial cardiolipin is required for Nlrp3 inflammasome activation. Immunity. 2013;39(2): 311-323.
57. Ehlers M, Fukuyama H, McGaha TL, Aderem A, Ravetch JV. TLR9/MyD88 signaling is required for class switching to pathogenic IgG2a and 2b autoantibodies in SLE. J Exp Med. 2006;203(3): 553-561.
58. Christensen SR, Shupe J, Nickerson K, Kashgarian M, Flavell RA, Shlomchik MJ. Toll-like receptor 7 and TLR9 dictate autoantibody specificity have opposing inflammatory regulatory roles in a murine model of lupus. Immunity. 2006;25(3): 417-428.
59. Hua Z, et al. Requirement for MyD88 signaling in B cells and dendritic cells for germinal center anti-nuclear antibody production in Lyn-deficient mice. J Immunol. 2014;192(3): 875-885.
60. Groom JR, et al. BAFF and MyD88 signals promote a lupuslike disease independent of T cells. J Exp Med. 2007;204(8): 1959-1971.
61. Lau CM, et al. RNA-Associated autoantigens activate B cells by combined B cell antigen recep- tor/Toll-like receptor 7 engagement. J Exp Med. 2005;202(9): 1171-1177.
62. Viglianti GA, Lau CM, Hanley TM, Miko BA, Shlomchik MJ, Marshak-Rothstein A. Activation of autoreactive B cells by CpG dsDNA. Immunity. 2003;19(6): 837-847.
63. Chaturvedi A, Dorward D, Pierce SK. The B cell receptor governs the subcellular location of Toll-like receptor 9 leading to hyperresponses to DNA-containing antigens. Immunity. 2008;28(6): 799-809.
64. Aranburu A, Ceccarelli S, Giorda E, Lasorella R, Ballatore G, Carsetti R. TLR ligation triggers somatic hypermutation in transitional B cells inducing the generation of IgM memory B cells. J Immunol. 2010;185(12): 7293-7301.
65. Giltiay NV, et al. Overexpression of TLR7 promotes cell-intrinsic expansion and autoantibody production by transitional T1 B cells. J Exp Med. 2013;210(12): 2773-2789.
66. Azulay-Debby H, Edry E, Melamed D. CpG DNA stimulates autoreactive immature B cells in the bone marrow. Eur J Immunol. 2007;37(6): 1463-1475.
67. Bernasconi NL, Onai N, Lanzavecchia A. A role for Toll-like receptors in acquired immunity: Up-regulation of TLR9 by BCR triggering in naive B cells constitutive expression in memory B cells. Blood. 2003;101(11): 4500-4504.
68. Bourke E, Bosisio D, Golay J, Polentarutti N, Mantovani A. The toll-like receptor repertoire of human B lymphocytes: Inducible and selective expression of TLR9 and TLR10 in normal transformed cells. Blood. 2003;102(3): 956-963.
69. Good KL, Avery DT, Tangye SG. Resting human memory B cells are intrinsically programmed for enhanced survival and responsiveness to diverse stimuli compared to naive B cells. J Immunol. 2009;182(2): 890-901.
70. Meyer-Bahlburg A, Khim S, Rawlings DJ. B cell intrinsic TLR signals amplify but are not required for humoral immunity. J Exp Med. 2007;204(13): 3095-3101.
71. Herlands RA, Christensen SR, Sweet RA, Hershberg U, Shlomchik MJ. T cell-independent and toll-like receptor-dependent antigen-driven activation of autoreactive B cells. Immunity. 2008;29(2): 249-260.
72. Bombardieri M, et al. A BAFF/APRIL-dependent TLR3-stimulated pathway enhances the capacity of rheumatoid synovial fibroblasts to induce AID expression and Ig class-switching in B cells. Ann Rheum Dis. 2011;70(10): 1857-1865.
73. Puga I, et al. B cell-helper neutrophils stimulate the diversification and production of immunoglobulin in the marginal zone of the spleen. Nat Immunol. 2012;13(2): 170-180.
74. Genestier L, Taillardet M, Mondiere P, Gheit H, Bella C, Defrance T. TLR agonists selectively promote terminal plasma cell differentiation of B cell subsets specialized in thymus-independent responses. J Immunol. 2007;178(12): 7779-7786.
75. Pone EJ, et al. BCR-signalling synergizes with TLR-signalling for induction of AID and immunoglobulin class-switching through the non-canonical NF-?B pathway. Nat Commun. 2012;3: 767.
76. Jiang W, Lederman MM, Harding CV, Rodriguez B, Mohner RJ, Sieg SF. TLR9 stimulation drives naive B cells to proliferate to attain enhanced antigen presenting function. Eur J Immunol. 2007;37(8): 2205-2213.
77. Boeglin E, Smulski CR, Brun S, Milosevic S, Schneider P, Fournel S. Toll-like receptor agonists synergize with CD40L to induce either proliferation or plasma cell differentiation of mouse B cells. PLoS One. 2011;6(10): E25542.
78. Gaynor B, Putterman C, Valadon P, Spatz L, Scharff MD, Diamond B. Peptide inhibition of glomerular deposition of an anti-DNA antibody. Proc Natl Acad Sci U S A. 1997;94(5): 1955-1960.
79. Raz E, Brezis M, Rosenmann E, Eilat D. Anti-DNA antibodies bind directly to renal antigens and induce kidney dysfunction in the isolated perfused rat kidney. J Immunol. 1989;142(9): 3076-3082.
80. Kuhn KA, et al. Antibodies against citrullinated proteins enhance tissue injury in experimental autoimmune arthritis. J Clin Invest. 2006;116(4): 961-973.
81. Uysal H, et al. Structure and pathogenicity of antibodies specific for citrullinated collagen type II in experimental arthritis. J Exp Med. 2009;206(2): 449-462.
82. Samarkos M, Davies KA, Gordon C, Loizou S. Clinical significance of IgA anticardiolipin and anti-β2-GP1 antibodies in patients with systemic lupus erythematosus primary antiphospholipid syndrome. Clin Rheumatol. 2006;25(2): 199-204.
83. Charles N, Hardwick D, Daugas E, Illei GG, Rivera J. Basophils and the T helper 2 environment can promote the development of lupus nephritis. Nat Med. 2010;16(6): 701-707.
84. Dema B, et al. Immunoglobulin E plays an immunoregulatory role in lupus. J Exp Med. 2014;211(11): 2159-2168.
85. Vas J, Gronwall C, Marshak-Rothstein A, Silverman GJ. Natural antibody to apoptotic cell membranes inhibits the proinflammatory properties of lupus autoantibody immune complexes. Arthritis Rheum. 2012;64(10): 3388-3398.
86. Son M, Santiago-Schwarz F, Al-Abed Y, Diamond B. C1q limits dendritic cell differentiation and activation by engaging LAIR-1. Proc Natl Acad Sci US A. 2012;109(46): E3160-E3167.
87. Boes M, Schmidt T, Linkemann K, Beaudette BC, Marshak-Rothstein A, Chen J. Accelerated development of IgG autoantibodies and autoimmune disease in the absence of secreted IgM. Proc Natl Acad Sci U S A. 2000;97(3): 1184-1189.
88. Zhao X, et al. Circulating immune complexes contain citrullinated fibrinogen in rheumatoid arthritis. Arthritis Res Ther. 2008;10(4): R94.
89. Trouw LA, et al. Anti-cyclic citrullinated peptide antibodies from rheumatoid arthritis patients activate complement via both the classical and alternative pathways. Arthritis Rheum. 2009;60(7): 1923-1931.
90. Ceribelli A, et al. Complement cascade in systemic lupus erythematosus: Analyses of the three activation pathways. Ann N Y Acad Sci. 2009;1173: 427-434.
91. Romero V, et al. Immune-mediated poreforming pathways induce cellular hypercitrullination and generate citrullinated autoantigens in rheumatoid arthritis. Sci Transl Med. 2013;5(209): 209ra150.
92. Lovgren T, Eloranta ML, Bave U, Alm GV, Ronnblom L. Induction of interferon-A production in plasmacytoid dendritic cells by immune complexes containing nucleic acid released by necrotic or late apoptotic cells and lupus IgG. Arthritis Rheum. 2004;50(6): 1861-1872.
93. Clavel C, et al. Induction of macrophage secretion of tumor necrosis factor a through Fc? receptor IIa engagement by rheumatoid arthritisspecific autoantibodies to citrullinated proteins complexed with fibrinogen. Arthritis Rheum. 2008;58(3): 678-688.
94. Suurmond J, et al. Toll-like receptor triggering augments activation of human mast cells by anti-citrullinated protein antibodies [published online ahead of print May 12, 2014]. Ann Rheum Dis. doi: 10.1136/annrheumdis-2014-205562.
95. Clynes R, Dumitru C, Ravetch JV. Uncoupling of immune complex formation and kidney damage in autoimmune glomerulonephritis. Science. 1998;279(5353): 1052-1054.
96. Park SY, et al. Resistance of Fc receptor-deficient mice to fatal glomerulonephritis. J Clin Invest. 1998;102(6): 1229-1238.
97. Sokolove J, et al. Rheumatoid factor as a potentiator of anti-citrullinated protein antibodymediated inflammation in rheumatoid arthritis. Arthritis Rheumatol. 2014;66(4): 813-821.
98. Ronnelid J, et al. Longitudinal analysis of citrullinated protein/peptide antibodies (anti-CP) during 5 year follow up in early rheumatoid arthritis: Anti-CP status predicts worse disease activity greater radiological progression. Ann Rheum Dis. 2005;64(12): 1744-1749.
99. Rantapaa-Dahlqvist S, et al. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum. 2003;48(10): 2741-2749.
100. Arbuckle MR, et al. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med. 2003;349(16): 1526-1533.
101. Verpoort KN, et al. Isotype distribution of anticyclic citrullinated peptide antibodies in undifferentiated arthritis and rheumatoid arthritis reflects an ongoing immune response. Arthritis Rheum. 2006;54(12): 3799-3808.
102. Suwannalai P, et al. Avidity maturation of anticitrullinated protein antibodies in rheumatoid arthritis. Arthritis Rheum. 2012;64(5): 1323-1328.
103. Rombouts Y, et al. Anti-citrullinated protein antibodies acquire a pro-inflammatory Fc glycosylation phenotype prior to the onset of rheumatoid arthritis. Ann Rheum Dis. 2015;74(1): 234-241.
104. Ioan-Facsinay A, et al. Marked differences in fine specificity and isotype usage of the anti-citrullinated protein antibody in health and disease. Arthritis Rheum. 2008;58(10): 3000-3008.
105. van de Stadt LA, et al. Development of the anti-citrullinated protein antibody repertoire prior to the onset of rheumatoid arthritis. Arthritis Rheum. 2011;63(11): 3226-3233.
106. Casciola-Rosen L, et al. Enhanced autoantigen expression in regenerating muscle cells in idiopathic inflammatory myopathy. J Exp Med. 2005;201(4): 591-601.
107. Sangaletti S, et al. Neutrophil extracellular traps mediate transfer of cytoplasmic neutrophil anti- gens to myeloid dendritic cells toward ANCA induction and associated autoimmunity. Blood. 2012;120(15): 3007-3018.
108. Khandpur R, et al. NETs are a source of citrullinated autoantigens and stimulate inflammatory responses in rheumatoid arthritis. Sci Transl Med. 2013;5(178): 178ra140.
109. Hakkim A, et al. Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis. Proc Natl Acad Sci U S A. 2010;107(21): 9813-9818.
110. Vogelpoel LT, et al. Fc gamma receptor-TLR cross-talk elicits pro-inflammatory cytokine production by human M2 macrophages. Nat Commun. 2014;5: 5444.
111. Suurmond J, Stoop JN, Rivellese F, Bakker AM, Huizinga TW, Toes RE. Activation of human basophils by combined toll-like receptor- And FceRI-triggering can promote Th2 skewing of naive T helper cells. Eur J Immunol. 2014;44(2): 386-396.